Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Common Equity (2020 - 2026)

Longeveron (LGVN) posted quarterly Common Equity of $16.0 million for Q1 2026, down 6.59% year-over-year from $17.2 million in Q1 2025, and up 182.41% quarter-over-quarter from $5.7 million in Q4 2025.

Longeveron (LGVN) Common Equity (2020 - 2026) Analysis & Trends

Longeveron's Common Equity history runs 7 years deep, the most recent figure standing at $16.0 million for Q1 2026.

  • In Q1 2026, Common Equity fell 6.59% year-over-year to $16.0 million; the TTM figure through Mar 2026 stood at $16.0 million (down 6.59% YoY), while the FY2025 annual figure was $5.7 million, down 74.07% from the prior year.
  • Common Equity for Q1 2026 stood at $16.0 million, up from $5.7 million in the prior quarter.
  • The five-year high for Common Equity was $34.3 million in Q1 2022, with the low at $3.0 million in Q1 2024.
  • The 5-year median for Common Equity is $16.0 million (2026), against an average of $16.3 million.
  • The sharpest annual moves came in 2024 and 2025: Common Equity tumbled 81.36% in 2024, then jumped 464.22% in 2025.
  • Longeveron's Common Equity stood at $20.5 million in 2022, then tumbled by 67.12% to $6.7 million in 2023, then surged by 224.68% to $21.9 million in 2024, then tumbled by 74.07% to $5.7 million in 2025, then surged by 182.41% to $16.0 million in 2026.
  • Business Quant data shows LGVN's Common Equity at $16.0 million in Q1 2026, $5.7 million in Q4 2025, and $10.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 6.76 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.17 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.35 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 22.38 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 757.49 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.79 Bn
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 10.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 10.40 Mn
Mar 31, 2026 16.03 Mn
Dec 31, 2025 5.68 Mn
Sep 30, 2025 9.97 Mn
Jun 30, 2025 12.66 Mn
Mar 31, 2025 17.16 Mn
Dec 31, 2024 21.89 Mn
Sep 30, 2024 25.63 Mn
Jun 30, 2024 14.91 Mn
Mar 31, 2024 3.04 Mn
Dec 31, 2023 6.74 Mn
Sep 30, 2023 6.63 Mn
Jun 30, 2023 11.26 Mn
Mar 31, 2023 16.32 Mn
Dec 31, 2022 20.50 Mn
Sep 30, 2022 24.62 Mn
Jun 30, 2022 29.38 Mn
Mar 31, 2022 34.31 Mn
Dec 31, 2021 37.45 Mn
Dec 31, 2020 1.96 Mn